Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Will

Pain Medicine Edina, MN Medical Doctor

NPI 1215997168 CMS profile 327795

7235 Ohms Ln, Edina, MN 55439

Open in the dashboard

General payments

$22,364

264 records reported · program years 2019–2025

Research payments

$43,421

Paid to them · 16 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$771,507 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Andrew Will of Edina, MN is reported in the CMS Open Payments database as having received $22,364 across 264 general payments and $43,421 in research payments paid to them. Separately, studies naming them as principal investigator received $771,507 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,538 16
2024 General $5,177 61
2023 General $7,283 67
2023 Research $2,698 1
2022 General $2,459 26
2021 General $1,562 24
2021 Research $24,877 11
2020 General $2,966 39
2020 Research $15,847 4
2019 General $1,378 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Will
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Andrew Will were reported at $1,538. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.

Show as a table
Year Andrew Will Pain Medicine median Middle half National median
2019 $1,378 $409 $115–$1,311 $163
2020 $2,966 $214 $66–$666 $114
2021 $1,562 $299 $84–$899 $132
2022 $2,459 $335 $103–$1,149 $149
2023 $7,283 $376 $114–$1,228 $160
2024 $5,177 $387 $115–$1,173 $164
2025 $1,538 $402 $130–$1,173 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $10,133 104 payments
  2. Abbott Laboratories $3,387 40 payments
  3. Boston Scientific Corporation $2,913 49 payments
  4. Medtronic USA, Inc. $2,769 34 payments
  5. SI-BONE, Inc. $1,125 5 payments
  6. Nevro Corp. $814 12 payments
  7. SPR Therapeutics, Inc $709 10 payments
  8. Vertos Medical, Inc. $145 1 payment
  9. Curonix LLC $98 1 payment
  10. BIOTRONIK NRO, Inc. $78 2 payments
  11. Other $192 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $13,629 233 payments
  2. Travel and Lodging $7,955 30 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $780 1 payment
Products named General payments · program years 2019–2025
  1. INTELLIS ADAPTIVESTIM $4,699 48 payments
  2. INTELLIS $1,994 19 payments
  3. KYPHON EXPRESS II KYPHOPAK TRAY $1,847 12 payments
  4. SYNCHROMEDII $1,782 17 payments
  5. PROCLAIM $1,754 11 payments
  6. WaveWriter Alpha Prime 16 $1,289 19 payments
  7. IFUSE IMPLANT SYSTEM $1,105 4 payments
  8. VANTA ADAPTIVESTIM $972 14 payments
  9. SPRINT PNS System $709 10 payments
  10. Proclaim Family of SCS IPGs $539 8 payments
  11. Other $5,369 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Boston Scientific Corporation $43,121 15 payments
  2. Nevro Corp. $300 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

207

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$1,701

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

31.9%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 63 $666
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 66 $531
Mupirocin Generic 78 $504

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$47,279

Of which drugs: $475

Medicare patients

163

Average age 69

Services billed

498

98 women, 65 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 66%
Depression 50%
Ischemic heart disease 27%
Diabetes 26%
Chronic kidney disease 22%
COPD 18%
Osteoporosis 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

280 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record